APA

Harth G., Horwitz M. A., Tabatadze D. & Zamecnik P. C. (20030114). Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Harth Günter, Horwitz Marcus A, Tabatadze David and Zamecnik Paul C. 20030114. Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Harth G., Horwitz M. A., Tabatadze D. and Zamecnik P. C. (20030114). Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Harth Günter, Horwitz Marcus A, Tabatadze David and Zamecnik Paul C. Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. : Proceedings of the National Academy of Sciences of the United States of America. 20030114.